title: First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.
abstract: Strain D958, a methicillin-resistant Staphylococcus aureus strain with reduced susceptibility to vancomycin, was isolated from a 69-year-old Saudi male patient presenting with severe sepsis immediately after admission. Despite high serum levels of vancomycin, the same S. aureus strain was isolated from five blood culture sets during 1 week. Treatment failure under therapeutic levels of vancomycin prompted us to investigate the resistance profile of this strain in further detail. The MIC values for vancomycin as determined by Etest and microdilution were 3.0 and 2.0 mg/liter, respectively, and remained unchanged during the treatment course. The macro-Etest method showed a MIC of 4 mg/liter. The strain showed liquid vancomycin and lysostaphin MBCs of 2.0 and 5.0 mg/liter, respectively. The isolates were confirmed as heterogeneously vancomycin-intermediate S. aureus (hVISA) by vancomycin population analysis profile. The areas under these curves were similar for Mu3 and D958 for vancomycin and teicoplanin (ratio values were 1 and 1.1 for vancomycin and teicoplanin, respectively). Extensive genotyping and molecular characterization demonstrated that the strain harbored a staphylococcal cassette chromosome mec element (SCCmec) type III cassette and was of sequence type ST241, a single-locus variant of the successful multiresistant clone ST239. Microarray results demonstrated that D958 contained numerous resistance determinants (generally plasmid or phage encoded). These results suggest that this strain is constitutively expressing an altered susceptibility to vancomycin. Further studies are warranted to assess the clonal distribution of such strains displaying reduced susceptibility to vancomycin prior to any antimicrobial therapy.
authors.affiliation: Microbiology Department, Security Forces Hospital Program, Kingdom of Saudi Arabia, P.O. Box 3643, Riyadh 11481, Saudi Arabia. obeid_jacques@hotmail.com
authors.forename: S
authors.initials: S
authors.lastname: Al-Obeid
authors.forename: Q
authors.initials: Q
authors.lastname: Haddad
authors.forename: A
authors.initials: A
authors.lastname: Cherkaoui
authors.forename: J
authors.initials: J
authors.lastname: Schrenzel
authors.forename: P
authors.initials: P
authors.lastname: François
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D015373:Bacterial Typing Techniques; D001769:Blood / Q000382:microbiology; D002876:Chromosomes, Bacterial; D016000:Cluster Analysis; D016172:DNA Fingerprinting; D004269:DNA, Bacterial / Q000235:genetics; D005798:Genes, Bacterial; D005838:Genotype; D006801:Humans; D008248:Lysostaphin / Q000494:pharmacology; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification*; D046228:Microarray Analysis; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability / Q000187:drug effects; D010957:Plasmids; D012529:Saudi Arabia; D018805:Sepsis / Q000382:microbiology*; D044967:Serum / Q000737:chemistry; D013203:Staphylococcal Infections / Q000382:microbiology*; D017334:Teicoplanin / Q000494:pharmacology; D014640:Vancomycin / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D017334:Teicoplanin; D014640:Vancomycin; D008248:Lysostaphin
references.citation: N Engl J Med. 2003 Apr 3;348(14):1342-7
references.pmid: 12672861
references.citation: J Clin Microbiol. 2004 Jun;42(6):2398-402
references.pmid: 15184410
references.citation: Antimicrob Agents Chemother. 2003 Jun;47(6):2036-9
references.pmid: 12760894
references.citation: J Clin Microbiol. 2007 Feb;45(2):329-32
references.pmid: 17108069
references.citation: J Clin Microbiol. 1999 Nov;37(11):3590-3
references.pmid: 10523558
references.citation: J Hosp Infect. 2007 Jun;65 Suppl 2:105-9
references.pmid: 17540252
references.citation: Lancet. 1998 Apr 18;351(9110):1212
references.pmid: 9643727
references.citation: J Clin Microbiol. 2008 Sep;46(9):2950-4
references.pmid: 18632899
references.citation: Clin Microbiol Infect. 2005 May;11(5):405-7
references.pmid: 15819869
references.citation: Clin Microbiol Infect. 2006 Apr;12 Suppl 2:3-10
references.pmid: 16524422
references.citation: Emerg Infect Dis. 2004 May;10(5):855-7
references.pmid: 15200819
references.citation: Ann Clin Microbiol Antimicrob. 2006 Dec 02;5:30
references.pmid: 17140452
references.citation: Clin Infect Dis. 1993 Sep;17(3):313-20; quiz 321-2
references.pmid: 8218670
references.citation: Ann Saudi Med. 2002 Jan-Mar;22(1-2):4-7
references.pmid: 17259757
references.citation: J Clin Microbiol. 2000 Mar;38(3):1008-15
references.pmid: 10698988
references.citation: BMC Genomics. 2006 Nov 22;7:296
references.pmid: 17121677
references.citation: J Clin Microbiol. 2006 Nov;44(11):3883-6
references.pmid: 16957043
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3040-5
references.pmid: 14506006
references.citation: Lancet. 1999 May 8;353(9164):1587-8
references.pmid: 10334262
references.citation: Diagn Microbiol Infect Dis. 2003 Feb;45(2):149-52
references.pmid: 12614988
references.citation: BMC Genomics. 2005 Jun 17;6:95
references.pmid: 15963225
references.citation: Clin Infect Dis. 2003 Feb 15;36(4):429-39
references.pmid: 12567300
references.citation: Emerg Infect Dis. 2008 Feb;14(2):304-7
references.pmid: 18258126
references.citation: Can J Microbiol. 2007 Aug;53(8):931-6
references.pmid: 17898849
references.citation: J Clin Microbiol. 2001 Feb;39(2):591-5
references.pmid: 11158112
references.citation: J Bacteriol. 2006 Feb;188(3):1120-33
references.pmid: 16428416
references.citation: Clin Infect Dis. 2007 May 1;44(9):1208-15
references.pmid: 17407040
references.citation: J Clin Microbiol. 2006 Mar;44(3):1040-8
references.pmid: 16517892
references.citation: Science. 2003 Nov 28;302(5650):1569-71
references.pmid: 14645850
references.citation: J Clin Microbiol. 2005 Jul;43(7):3346-55
references.pmid: 16000459
references.citation: Clin Infect Dis. 2004 Feb 15;38(4):521-8
references.pmid: 14765345
references.citation: Lancet. 2001 Apr 21;357(9264):1225-40
references.pmid: 11418146
references.citation: Antimicrob Agents Chemother. 2008 Oct;52(10):3755-62
references.pmid: 18644967
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):2687-92
references.pmid: 15980337
references.citation: J Clin Microbiol. 2001 Dec;39(12):4445-51
references.pmid: 11724859
references.citation: Clin Microbiol Infect. 2003 Dec;9(12):1179-86
references.pmid: 14686982
references.citation: J Clin Microbiol. 2000 Oct;38(10):3879-81
references.pmid: 11015427
references.citation: Biol Direct. 2009 Jan 13;4:1
references.pmid: 19144117
references.citation: Am J Med. 1986 Jul;81(1):43-52
references.pmid: 3524225
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Oct 11;51(40):902
references.pmid: 12418544
references.citation: Clin Infect Dis. 2007 Nov 1;45(9):1132-40
references.pmid: 17918074
references.citation: Med J Aust. 2001 Nov 5;175(9):480-3
references.pmid: 11758077
references.citation: J Clin Microbiol. 2008 Apr;46(4):1520-2
references.pmid: 18234867
references.citation: Clin Infect Dis. 2008 Mar 1;46(5):668-74
references.pmid: 18257700
references.citation: J Antimicrob Chemother. 2002 Dec;50(6):1017-26
references.pmid: 12461026
references.citation: J Clin Microbiol. 2005 Nov;43(11):5445-51
references.pmid: 16272468
references.citation: Clin Infect Dis. 2005 Sep 15;41(6):771-7
references.pmid: 16107972
references.citation: J Antimicrob Chemother. 2006 Jan;57(1):146-9
references.pmid: 16286482
references.citation: Antimicrob Agents Chemother. 2008 Dec;52(12):4510-3
references.pmid: 18838583
references.citation: Clin Infect Dis. 2004 Apr 15;38(8):1188-91
references.pmid: 15095227
references.citation: J Antimicrob Chemother. 2000 Feb;45(2):258-9
references.pmid: 10660514
references.citation: J Antimicrob Chemother. 2001 Feb;47(2):163-70
references.pmid: 11157900
references.citation: Proc Natl Acad Sci U S A. 2007 May 29;104(22):9451-6
references.pmid: 17517606
references.citation: Rev Assoc Med Bras (1992). 1995 Jan-Feb;41(1):47-52
references.pmid: 7550414
references.citation: Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S31-4
references.pmid: 11137406
references.citation: Antimicrob Agents Chemother. 2009 Sep;53(9):3642-9
references.pmid: 19546358
references.citation: J Clin Microbiol. 2003 Jan;41(1):5-14
references.pmid: 12517819
references.citation: Lancet. 1997 Dec 6;350(9092):1670-3
references.pmid: 9400512
references.citation: Antimicrob Agents Chemother. 2004 Jun;48(6):1953-9
references.pmid: 15155184
references.citation: J Antimicrob Chemother. 2006 Apr;57(4):699-704
references.pmid: 16464892
references.citation: Eur J Clin Microbiol Infect Dis. 2001 Oct;20(10):685-97
references.pmid: 11757969
references.citation: Am J Med. 1998 May 29;104(5A):7S-10S
references.pmid: 9684652
references.citation: J Antimicrob Chemother. 2004 Dec;54(6):1045-50
references.pmid: 15531598